Paul R. Fonteyne is Director at Apellis Pharmaceuticals, Inc. (APLS). They have made 3 open-market trades across 3 companies since 2020, most recently 2026-01-01.
CIK 0001727550
3 open-market purchases totalling $466K since 2020, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.